Annual Total Liabilities
$36.88 M
+$4.23 M+12.95%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual total liabilities is $36.88 million, with the most recent change of +$4.23 million (+12.95%) on December 31, 2023.
- During the last 3 years, XENE annual total liabilities has risen by +$19.05 million (+106.81%).
- XENE annual total liabilities is now -33.82% below its all-time high of $55.72 million, reached on December 31, 2019.
Performance
XENE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$38.09 M
-$1.87 M-4.68%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly total liabilities is $38.09 million, with the most recent change of -$1.87 million (-4.68%) on September 30, 2024.
- Over the past year, XENE quarterly total liabilities has dropped by -$1.87 million (-4.68%).
- XENE quarterly total liabilities is now -31.63% below its all-time high of $55.72 million, reached on December 31, 2019.
Performance
XENE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
XENE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.9% | -4.7% |
| 3 y3 years | +106.8% | -0.9% |
| 5 y5 years | +92.7% | -0.9% |
XENE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.8% | -4.7% | +135.1% |
| 5 y | 5-year | -33.8% | +106.8% | -31.6% | +164.7% |
| alltime | all time | -33.8% | +1165.1% | -31.6% | +1206.8% |
Xenon Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $38.09 M(-4.7%) |
| Jun 2024 | - | $39.96 M(+27.6%) |
| Mar 2024 | - | $31.32 M(-15.1%) |
| Dec 2023 | $36.88 M(+12.9%) | $36.88 M(+6.9%) |
| Sep 2023 | - | $34.50 M(-10.3%) |
| Jun 2023 | - | $38.44 M(+16.8%) |
| Mar 2023 | - | $32.92 M(+0.8%) |
| Dec 2022 | $32.65 M(+48.6%) | $32.65 M(+43.9%) |
| Sep 2022 | - | $22.69 M(+5.1%) |
| Jun 2022 | - | $21.59 M(+33.2%) |
| Mar 2022 | - | $16.21 M(-26.2%) |
| Dec 2021 | $21.97 M(+23.2%) | $21.97 M(+42.6%) |
| Sep 2021 | - | $15.41 M(-13.1%) |
| Jun 2021 | - | $17.73 M(+23.2%) |
| Mar 2021 | - | $14.39 M(-19.3%) |
| Dec 2020 | $17.83 M(-68.0%) | $17.83 M(+4.2%) |
| Sep 2020 | - | $17.11 M(-20.0%) |
| Jun 2020 | - | $21.38 M(-56.4%) |
| Mar 2020 | - | $49.06 M(-11.9%) |
| Dec 2019 | $55.72 M | $55.72 M(+128.9%) |
| Sep 2019 | - | $24.34 M(+5.3%) |
| Jun 2019 | - | $23.11 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $22.24 M(+16.2%) |
| Dec 2018 | $19.13 M(+87.8%) | $19.13 M(-0.9%) |
| Sep 2018 | - | $19.30 M(+30.3%) |
| Jun 2018 | - | $14.81 M(+59.9%) |
| Mar 2018 | - | $9.26 M(-9.1%) |
| Dec 2017 | $10.19 M(+184.1%) | $10.19 M(+233.1%) |
| Sep 2017 | - | $3.06 M(-19.0%) |
| Jun 2017 | - | $3.77 M(+5.1%) |
| Mar 2017 | - | $3.59 M(+0.1%) |
| Dec 2016 | $3.59 M(+23.0%) | $3.59 M(-11.7%) |
| Sep 2016 | - | $4.06 M(+34.1%) |
| Jun 2016 | - | $3.03 M(+1.4%) |
| Mar 2016 | - | $2.99 M(+2.5%) |
| Dec 2015 | $2.92 M(-80.1%) | $2.92 M(-46.9%) |
| Sep 2015 | - | $5.49 M(-55.0%) |
| Jun 2015 | - | $12.18 M(+16.7%) |
| Mar 2015 | - | $10.43 M(-28.7%) |
| Dec 2014 | $14.64 M(-51.8%) | $14.64 M(-23.6%) |
| Sep 2014 | - | $19.16 M(-18.8%) |
| Jun 2014 | - | $23.61 M(-22.3%) |
| Dec 2013 | $30.37 M(-40.1%) | $30.37 M |
| Dec 2012 | $50.68 M | - |
FAQ
- What is Xenon Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual total liabilities year-on-year change?
- What is Xenon Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly total liabilities year-on-year change?
What is Xenon Pharmaceuticals annual total liabilities?
The current annual total liabilities of XENE is $36.88 M
What is the all time high annual total liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual total liabilities is $55.72 M
What is Xenon Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, XENE annual total liabilities has changed by +$4.23 M (+12.95%)
What is Xenon Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of XENE is $38.09 M
What is the all time high quarterly total liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly total liabilities is $55.72 M
What is Xenon Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, XENE quarterly total liabilities has changed by -$1.87 M (-4.68%)